• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊柱融合术骨替代物的最新进展。

An update on bone substitutes for spinal fusion.

作者信息

Miyazaki Masashi, Tsumura Hiroshi, Wang Jeffrey C, Alanay Ahmet

机构信息

Department of Orthopaedic Surgery, Oita University, Oita, 879-5593, Japan.

出版信息

Eur Spine J. 2009 Jun;18(6):783-99. doi: 10.1007/s00586-009-0924-x. Epub 2009 Mar 12.

DOI:10.1007/s00586-009-0924-x
PMID:19280232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2899672/
Abstract

With the current advances in spinal surgery, an understanding of the precise biological mechanism of each bone substitute is necessary for inducing successful spinal fusion. In this review, the categories of bone substitutes include allografts, ceramics, demineralized bone matrix, osteoinductive factors, autogenous platelet concentrate, mesenchymal stem cells, and gene therapy. Further, clinical studies have been evaluated by their levels of evidence in order to elucidate the precise effect of the bone substitute employed and to establish clinical guidance. This article will review both clinical studies based on evidence and basic research in current advances in order to avoid as far as possible any chances of failure in the future and to understand cellular biology in novel technologies.

摘要

随着脊柱外科手术的当前进展,了解每种骨替代物的确切生物学机制对于诱导成功的脊柱融合是必要的。在本综述中,骨替代物的类别包括同种异体移植物、陶瓷、脱矿骨基质、骨诱导因子、自体血小板浓缩物、间充质干细胞和基因治疗。此外,已根据其证据水平对临床研究进行了评估,以阐明所采用骨替代物的确切效果并建立临床指导。本文将回顾基于证据的临床研究和当前进展中的基础研究,以尽可能避免未来任何失败的可能性,并了解新技术中的细胞生物学。

相似文献

1
An update on bone substitutes for spinal fusion.脊柱融合术骨替代物的最新进展。
Eur Spine J. 2009 Jun;18(6):783-99. doi: 10.1007/s00586-009-0924-x. Epub 2009 Mar 12.
2
Current use of biologic graft extenders for spinal fusion.生物移植物增强剂在脊柱融合术中的当前应用。
J Neurosurg Sci. 2012 Sep;56(3):203-7.
3
Bone graft substitutes for use in spinal fusions.用于脊柱融合术的骨移植替代物。
Clin Neurosurg. 2005;52:250-5.
4
The role of osteobiologics in spinal deformity.骨生物制剂在脊柱畸形中的作用。
Neurosurg Clin N Am. 2007 Apr;18(2):393-401. doi: 10.1016/j.nec.2007.01.002.
5
Bone Graft Options in Spinal Fusion: A Review of Current Options and the Use of Mesenchymal Cellular Bone Matrices.脊柱融合中的骨移植选择:当前选择的回顾及间充质细胞骨基质的应用。
World Neurosurg. 2022 Feb;158:182-188. doi: 10.1016/j.wneu.2021.11.130. Epub 2021 Dec 4.
6
Instrumented posterolateral lumbar fusion using coralline hydroxyapatite with or without demineralized bone matrix, as an adjunct to autologous bone.使用含或不含脱矿骨基质的珊瑚羟基磷灰石作为自体骨的辅助材料进行器械辅助腰椎后外侧融合术。
Spine J. 2001 Mar-Apr;1(2):131-7. doi: 10.1016/s1529-9430(01)00011-0.
7
Bone graft substitutes for spinal fusion.用于脊柱融合的骨移植替代物。
Spine J. 2003 Mar-Apr;3(2):155-65. doi: 10.1016/s1529-9430(02)00539-9.
8
Biomaterials and Bioactive Agents in Spinal Fusion.脊柱融合中的生物材料和生物活性剂。
Tissue Eng Part B Rev. 2017 Dec;23(6):540-551. doi: 10.1089/ten.TEB.2017.0072. Epub 2017 Jun 28.
9
Osteoinductive bone graft substitutes for spinal fusion: a basic science summary.用于脊柱融合的骨诱导性骨移植替代物:基础科学总结
Orthop Clin North Am. 1999 Oct;30(4):635-45. doi: 10.1016/s0030-5898(05)70116-4.
10
Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion.使用促骨生长因子、脱矿骨基质和陶瓷来增强脊柱融合。
J Am Acad Orthop Surg. 2005 Mar-Apr;13(2):129-37. doi: 10.5435/00124635-200503000-00006.

引用本文的文献

1
Ceramic substitutes, failure to achieve solid fusion in posterolateral instrumented fusion: a surgical and histological evaluation.陶瓷替代物,后侧器械辅助融合中未能实现牢固融合:一项手术及组织学评估
Eur Spine J. 2025 Jan;34(1):156-162. doi: 10.1007/s00586-024-08476-3. Epub 2024 Sep 21.
2
The benefit of antibiotic-combined Mg-hydroxyapatite bone graft substitute over autologous bone for surgical site infection prevention in posterolateral spinal fusion: a retrospective cohort study.抗生素联合镁羟基磷灰石骨移植替代物与自体骨在预防后外侧脊柱融合手术部位感染方面的比较:一项回顾性队列研究
Ann Med Surg (Lond). 2023 Apr 27;85(6):2341-2347. doi: 10.1097/MS9.0000000000000728. eCollection 2023 Jun.
3
Ceramic bone graft substitute (Mg-HA) in spinal fusion: A prospective pilot study.陶瓷骨移植替代物(镁羟基磷灰石)用于脊柱融合术:一项前瞻性初步研究。
Front Bioeng Biotechnol. 2022 Nov 17;10:1050495. doi: 10.3389/fbioe.2022.1050495. eCollection 2022.
4
Enhanced bone regenerative properties of calcium phosphate ceramic granules in rabbit posterolateral spinal fusion through a reduction of grain size.通过减小粒径增强磷酸钙陶瓷颗粒在兔后外侧脊柱融合中的骨再生特性。
Bioact Mater. 2021 Oct 8;11:90-106. doi: 10.1016/j.bioactmat.2021.10.006. eCollection 2022 May.
5
Allografts and Spinal Fusion.同种异体移植物与脊柱融合术
Int J Spine Surg. 2021 Apr;15(s1):68-93. doi: 10.14444/8056. Epub 2021 Apr 21.
6
Efficacy of platelet-rich plasma in posterior lumbar interbody fusion: systematic review and meta-analysis.富血小板血浆在后路腰椎椎体间融合术中的疗效:系统评价和荟萃分析。
Eur J Orthop Surg Traumatol. 2020 May;30(4):583-593. doi: 10.1007/s00590-019-02603-3. Epub 2019 Dec 20.
7
rhBMP2 alone does not induce macrophage polarization towards an increased inflammatory response.rhBMP2 单独使用不会诱导巨噬细胞向增强的炎症反应方向极化。
Mol Immunol. 2020 Jan;117:94-100. doi: 10.1016/j.molimm.2019.10.021. Epub 2019 Nov 20.
8
Interbody options in lumbar fusion.腰椎融合术中的椎间融合器选择
J Spine Surg. 2019 Jun;5(Suppl 1):S19-S24. doi: 10.21037/jss.2019.04.04.
9
ISASS Recommendations and Coverage Criteria for Bone Graft Substitutes used in Spinal Surgery.脊柱手术中骨移植替代物的ISASS建议和覆盖标准。
Int J Spine Surg. 2018 Dec 21;12(6):757-771. doi: 10.14444/5095. eCollection 2018 Dec.
10
[Lumbar fusion-Indications and techniques].[腰椎融合术——适应证与技术]
Orthopade. 2019 Jan;48(1):50-58. doi: 10.1007/s00132-018-03670-w.

本文引用的文献

1
The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.富集骨髓干细胞联合多孔β-磷酸三钙在后路脊柱融合术中的临床应用
Biomaterials. 2008 Oct;29(29):3973-82. doi: 10.1016/j.biomaterials.2008.06.026. Epub 2008 Jul 18.
2
The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.用产生骨形态发生蛋白-2的骨髓细胞进行慢病毒基因治疗对大鼠脊柱融合的影响。
J Spinal Disord Tech. 2008 Jul;21(5):372-9. doi: 10.1097/BSD.0b013e31814cf51d.
3
Effect of Hydroxyapatite porous characteristics on healing outcomes in rabbit posterolateral spinal fusion model.羟基磷灰石多孔特性对兔后外侧脊柱融合模型愈合结果的影响。
Eur Spine J. 2007 Dec;16(12):2215-24. doi: 10.1007/s00586-007-0501-0. Epub 2007 Sep 22.
4
Introduction to and techniques of evidence-based medicine.循证医学导论与技术
Spine (Phila Pa 1976). 2007 Sep 1;32(19 Suppl):S66-72. doi: 10.1097/BRS.0b013e318145308d.
5
Demineralized bone matrix composite grafting for posterolateral spinal fusion.脱矿骨基质复合材料植骨用于后外侧脊柱融合术
Orthopedics. 2007 Jul;30(7):567-70. doi: 10.3928/01477447-20070701-06.
6
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.OP-1(重组人骨形态发生蛋白-7)替代髂嵴自体骨用于腰椎后外侧融合术的安全性和有效性:一项初步研究的至少4年随访
Spine J. 2008 May-Jun;8(3):457-65. doi: 10.1016/j.spinee.2007.03.012. Epub 2007 May 25.
7
Regulation of transgene expression using an inducible system for improved safety of intervertebral disc gene therapy.使用诱导系统调控转基因表达以提高椎间盘基因治疗的安全性。
Spine (Phila Pa 1976). 2007 Jun 1;32(13):1381-7. doi: 10.1097/BRS.0b013e3180601215.
8
Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.通过将重组人骨形态发生蛋白-2(rhBMP-2)与同种异体骨相结合来加速腰椎融合:椎间融合率及临床结果的前瞻性分析
Spine J. 2007 May-Jun;7(3):301-7. doi: 10.1016/j.spinee.2006.10.015. Epub 2007 Jan 2.
9
Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.使用重组人骨形态发生蛋白-2进行颈椎前路椎间盘切除融合术的并发症。
Eur Spine J. 2007 Aug;16(8):1257-65. doi: 10.1007/s00586-007-0351-9. Epub 2007 Mar 27.
10
Level of evidence in Spine compared to other orthopedic journals.与其他骨科期刊相比,《脊柱》杂志的证据水平。
Spine (Phila Pa 1976). 2007 Feb 1;32(3):388-93. doi: 10.1097/01.brs.0000254109.12449.6c.